Physician profile
Yu Zheng
NPI 1588193320
$5,428.83
in general payments reported to CMS, 2019-2025
11 companies · $1,711 in 2025
The $1,711 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $792 · 2021: $251 · 2022: $228 · 2023: $318 · 2024: $1,595 · 2025: $1,711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,949 · Consulting Fee: $875 · Travel and Lodging: $799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,949.44 |
| Consulting Fee | $875.00 |
| Travel and Lodging | $799.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,612.26 | 2019-2025 | Upsylon, Advantage System, Ams 700 Cxr Rte Kit |
| Medtronic, INC. | $1,303.68 | 2023-2025 | Interstim |
| Verathon INC. | $875.00 | 2025 | Npd Clinical Study |
| Coloplast Corp | $691.32 | 2020-2022 | |
| Abbvie INC. | $326.05 | 2025 | |
| Becton, Dickinson and Company | $213.63 | 2025 | Arista |
| Travere Therapeutics, INC. | $117.14 | 2019 | |
| Endo Pharmaceuticals INC. | $113.75 | 2019 | |
| Axonics, INC. | $89.88 | 2024 | Axonics, Bulkamid |
| Allergan, INC. | $49.83 | 2022 | |
| Karl Storz Endoscopy-America | $36.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yu Zheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.